Trial intelligence / Profile preview

Valproic Acid in Advanced Thyroid Cancer

NCT01182285Phase 2Completed

Sponsor
National Cancer Institute
Start
Sep 2010
Primary completion
Sep 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of valproic acid in Follicular thyroid cancer (FTC), sponsored by National Cancer Institute. Started Sep 2010; status: completed.

02

Drugs

valproic acid
03

Conditions

Follicular thyroid cancer (FTC)

Beyond the preview

Go deeper on NCT01182285.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01182285.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call